Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Aims Adherence to highly active antiretroviral therapy (HAART) is a key predictor of survival for human immunodeficiency virus (HIV)‐infected people. Suboptimal adherence among marginalized populations such as HIV‐positive drug users could be associated with clinical failure and the emergence of viral resistance. Objective To conduct a systematic review of studies assessing adherence to HAART among HIV‐positive drug users (DU) and identify factors associated with non‐adherence to HIV treatment. Data sources Seven electronic databases were searched for peer‐reviewed papers published in English, French, Spanish or Portuguese, from 1996 to 2007. Study selection and data abstraction Studies were excluded if they presented only qualitative data, were reviews themselves or assessed other populations without disaggregating data on DU. Findings on adherence were extracted and summarized. Data synthesis Forty‐one studies were considered, which studied a total of 15 194 patients, the majority of whom were HIV‐positive DU (n = 11 628, 76.5%). Twenty‐two studies assessed adherence using patient self‐reports, eight used pharmacy records, three used electronic monitoring [i.e. Medication Event Monitoring Systems (MEMS) caps], six studies used a combination of patient self‐report, clinical data and MEMS‐caps, and two analyzed secondary data. Overall, active substance use was associated with poor adherence, as well as depression and low social support. Higher adherence was found in patents receiving care in structured settings (e.g. directly observed therapy) and/or drug addiction treatment (especially substitution therapy). Conclusion While lower than other populations—especially among users of stimulants, incarcerated DU and patients with psychiatric comorbidities—adherence to HAART among HIV‐positive DU can be achieved. Better adherence was identified among those engaged in comprehensive services providing HIV and addiction treatment with psychosocial support.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00004 · Cited by 3,289
Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A., & Moss, A. (2000) · AIDS · doi:10.1097/00002030-200003100-00008 · Cited by 1,033
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., & Moss, A. (2001) · AIDS · doi:10.1097/00002030-200106150-00015 · Cited by 960
Sociodemographic and psychological variables influencing adherence to antiretroviral therapy
Gordillo, V., del Amo, J., Soriano, V., & González-Lahoz, J. (1999) · AIDS · doi:10.1097/00002030-199909100-00021 · Cited by 658
Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C., Buono, D., Eckholdt, H., Howard, A. A., & Schoenbaum, E. E. (2001) · Clinical Infectious Diseases · doi:10.1086/323201 · Cited by 637
Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002) · Journal of General Internal Medicine · doi:10.1007/s11606-002-0044-3 · Cited by 501
Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance
Wainberg, M. A. (1998) · JAMA · doi:10.1001/jama.279.24.1977 · Cited by 498
Trust and the Acceptance of and Adherence to Antiretroviral Therapy
Altice, F. L., Mostashari, F., & Friedland, G. H. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200109010-00008 · Cited by 410
Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV-1 Infection
Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200107010-00006 · Cited by 350
Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence
Mannheimer, S. B., Matts, J., Telzak, E., Chesney, M., Child, C., Wu, A. W., Friedland, G., & Progr, F. T. T. B. C. (2005) · AIDS Care · doi:10.1080/09540120412331305098 · Cited by 331
Lucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002) · AIDS · doi:10.1097/00002030-200203290-00012 · Cited by 320
Drug Use and Medication Adherence among HIV-1 Infected Individuals
Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., Myers, H. F., & Longshore, D. (2007) · AIDS and Behavior · doi:10.1007/s10461-006-9152-0 · Cited by 305
Self-reported Antiretroviral Therapy in Injection Drug Users
Celentano, D. D. (1998) · JAMA · doi:10.1001/jama.280.6.544 · Cited by 258
High levels of adherence do not prevent accumulation of HIV drug resistance mutations
Bangsberg, D. R., Charlebois, E. D., Grant, R. M., Holodniy, M., Deeks, S. G., Perry, S., Conroy, K. N., Clark, R., Guzman, D., Zolopa, A., et al. (2003) · AIDS · doi:10.1097/00002030-200309050-00011 · Cited by 256
Hiv, G. B. C. O. (2005) · UNAIDS eBooks · Cited by 236
Moatti, J. P., Carrieri, M. P., Spire, B., Gastaut, J. A., Cassuto, J. P., & Moreau, J. (2000) · AIDS · doi:10.1097/00002030-200001280-00010 · Cited by 220
Turner, B. J., Laine, C., Cosler, L., & Hauck, W. W. (2003) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2003.20122.x · Cited by 218
Palepu, A., Tyndall, M. W., Joy, R., Kerr, T., Wood, E., Press, N., Hogg, R. S., & Montaner, J. S. G. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.02.003 · Cited by 207
Medication Development for Addictive Disorders: The State of the Science
Vocci, F. J., Acri, J., & Elkashef, A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1432 · Cited by 190
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users
Celentano, D. D., Galai, N., Sethi, A. K., Shah, N. G., Strathdee, S. A., Vlahov, D., & Gallant, J. E. (2001) · AIDS · doi:10.1097/00002030-200109070-00015 · Cited by 189
Self-citationthe MANIF 2000 Study Group, Bouhnik, A.-D., Préau, M., Vincent, E., Carrieri, M. P., Gallais, H., Lepeu, G., Gastaut, J.-A., Moatti, J.-P., & Spire, B. (2005) · Antiviral Therapy · doi:10.1177/135965350501000103 · Cited by 182
Bassetti, S., Battegay, M., Furrer, H., Rickenbach, M., Flepp, M., Kaiser, L., Telenti, A., Vernazza, P., Bernasconi, E., & Sudre, P. (1999) · PubMed · Cited by 160
Palepu, A., Horton, N. J., Tibbetts, N., Meli, S., & Samet, J. H. (2004) · Addiction · doi:10.1111/j.1360-0443.2003.00670.x · Cited by 160
McNabb, J., Ross, J. W., Abriola, K., Turley, C., Nightingale, C. H., & Nicolau, D. P. (2001) · Clinical Infectious Diseases · doi:10.1086/322590 · Cited by 152
Nonadherence Among HIV-Infected Injecting Drug Users: The Impact of Social Instability
Bouhnik, A.-D., Chesney, M., Carrieri, P., Gallais, H., Moreau, J., Moatti, J.-P., Obadia, Y., & Spire, B. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200212153-00013 · Cited by 135
Palepu, A., Tyndall, M., Yip, B., O'Shaughnessy, M. V., Hogg, R. S., & Montaner, J. S. G. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200304150-00009 · Cited by 127
Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'Shaughnessy, M. V., & Montaner, J. S. (2003) · AIDS · doi:10.1097/00002030-200303280-00009 · Cited by 125
Palepu, A., Tyndall, M. W., Chan, K., Wood, E., Montaner, J. S., & Hogg, R. S. (2004) · Antiviral Therapy · doi:10.1177/135965350400900503 · Cited by 121 · cited 2×
“Kerr and colleagues [50] evaluated the underlying reasons for HAART discontinuation among IDU in Vancouver, Canada, where 44% dis- continued HAART during a 1-year follow-up period.”
Parsons, J. T., Rosof, E., Punzalan, J. C., & Maria, L. D. (2005) · AIDS Patient Care and STDs · doi:10.1089/apc.2005.19.31 · Cited by 115
Altice, F. L., Mezger, J. A., Hodges, J., Bruce, R. D., Marinovich, A., Walton, M., Springer, S. A., & Friedland, G. H. (2004) · Clinical Infectious Diseases · doi:10.1086/421400 · Cited by 109
Failure to maintain adherence to haart in a cohort of French HIV-positive injecting drug users
Carrieri, P., Chesney, M. A., Spire, B., Loundou, A., Sobel, A. T., Lepeu, G., & Moatti, J. (2003) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm1001_01 · Cited by 103
Inciardi, J. A., & Surratt, H. L. (2001) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2001.10399923 · Cited by 102
Pharmacotherapy and other treatments for cocaine abuse and dependence
Vocci, F. J., & Elkashef, A. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165596.98552.02 · Cited by 100
Crack Cocaine Use and Adherence to Antiretroviral Treatment Among HIV-Infected Black Women
Sharpe, T. T., Lee, L. M., Nakashima, A. K., Elam–Evans, L. D., & Fleming, P. L. (2004) · Journal of Community Health · doi:10.1023/b:johe.0000016716.99847.9b · Cited by 97
Knowlton, A., Arnsten, J., Eldred, L., Wilkinson, J., Gourevitch, M., Shade, S., Dowling, K., & Purcell, D. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000186392.26334.e3 · Cited by 97
Determinants of HAART discontinuation among injection drug users
Kerr, T., Marshall, A., Walsh, J., Palepu, A., Tyndall, M., Montaner, J., Hogg, R., & Wood, E. (2005) · AIDS Care · doi:10.1080/09540120412331319778 · Cited by 93
Purcell, D. W., Metsch, L. R., Latka, M. H., Santibanez, S. S., Gomez, C. A., Eldred, L. J., & Latkin, C. A. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000140609.44016.c4 · Cited by 92
Arnsten, J. H., Li, X., Mizuno, Y., Knowlton, A. R., Gourevitch, M. N., Handley, K., Knight, K. R., & Metsch, L. R. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815767d6 · Cited by 90
Wagner, G. J., & Ryan, G. W. (2004) · AIDS Patient Care and STDs · doi:10.1089/1087291041518238 · Cited by 87
Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world
Wood, E., Montaner, J. S. G., Bangsberg, D. R., TYNDALL, M. W., Strathdee, S. A., O’Shaughnessy, M. V., & Hogg, R. S. (2003) · AIDS · doi:10.1097/00002030-200311210-00003 · Cited by 86
Self-citationWang, C., Vlahov, D., Galai, N., Bareta, J., Strathdee, S. A., Nelson, K. E., & Sterling, T. R. (2004) · The Journal of Infectious Diseases · doi:10.1086/422848 · Cited by 85
Self-citationWaldrop-Valverde, D., & Valverde, E. (2005) · AIDS Patient Care and STDs · doi:10.1089/apc.2005.19.326 · Cited by 80
Palepu, A., TYNDALL, M. W., Li, K., Yip, B., O'Shaughnessy, M. V., Schechter, M. T., Montaner, J. S. G., & Hogg, R. S. (2003) · Journal of Heredity · doi:10.1093/jurban/jtg073 · Cited by 71
Kerr, T. H., Palepu, A., Barnes, G. E., Walsh, J. C., Hogg, R. S., Montaner, J. S. G., TYNDALL, M. W., & Wood, E. (2004) · Antiviral Therapy · doi:10.1177/135965350400900314 · Cited by 66
Smith-Rohrberg, D., Mezger, J., Walton, M. R., Bruce, R. D., & Altice, F. L. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000248338.74943.85 · Cited by 64
Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS
Crystal, S., Sambamoorthi, U., Moynihan, P. J., & McSpiritt, E. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.01025.x · Cited by 62
Patient-perceived barriers to antiretroviral adherence: Associations with race
Ferguson, T. F., Stewart, K. E., Funkhouser, E., Tolson, J., Westfall, A. O., & Saag, M. S. (2002) · AIDS Care · doi:10.1080/0954012021000005434 · Cited by 61
Neurocognitive Aspects of Medication Adherence in HIV-Positive Injecting Drug Users
Waldrop‐Valverde, D., Ownby, R. L., Wilkie, F. L., Mack, A., Kumar, M., & Metsch, L. R. (2006) · AIDS and Behavior · doi:10.1007/s10461-005-9062-6 · Cited by 55
Liu, H., Longshore, D. L., Williams, J. K. Y., Rivkin, I. D., Loeb, T. B., Warda, U. S., Carmona, J. V., & Wyatt, G. E. (2006) · AIDS and Behavior · doi:10.1007/s10461-005-9041-y · Cited by 46
Comment: factors affecting patient adherence to highly active antiretroviral therapy
Ngo, C., & Sansgiry, S. S. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1c427a · Cited by 36
Haug, N. A., Sorensen, J. L., Lollo, N., Gruber, V. A., Delucchi, K., & Hall, S. M. (2005) · AIDS Care · doi:10.1080/09540120500100882 · Cited by 34
Factors Affecting Patient Adherence to Highly Active Antiretroviral Therapy
Escobar, I., Campo, M., Martín‐Fernández, J., Fernández-Shaw, C., Pulido, F., & Rubio, R. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c427 · Cited by 33
Pradier, C., Carrieri, P., Bentz, L., Spire, B., Dellamonica, P., Moreau, J., & Moatti, J. (2001) · International Journal of STD & AIDS · doi:10.1258/0956462011923165 · Cited by 31
Placebo Practice Trials: The Best Predictor of Adherence Readiness for HAART Among Drug Users?
Glenn, W. (2003) · HIV Clinical Trials · doi:10.1310/yvtr-t8ev-3tq6-qajc · Cited by 27
Illicit Drug Use: Can it Predict Adherence to Antiretroviral Therapy?
Martini, M., Recchia, E., Nasta, P., Castanotto, D., Chiaffarino, F., Parazzini, F., & Agnoletto, V. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000032353.03967.ef · Cited by 26
Martín, L. L., Hernández, S. O., & Carrobles, J. A. (2005) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 25
McCance‐Katz, E. F., Kosten, T. A., & Kosten, T. R. (2001) · Psychopharmacology · doi:10.1007/s002130100745 · Cited by 18
Oke, M. A. (2016) · University of Malaya Students Repository · doi:10.1046/j.1468-1293.2003.00130.x · Cited by 1
Cited by
Determinants of patient adherence: a review of systematic reviews
Kardas, P., Lewek, P., & Matyjaszczyk, M. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00091 · Cited by 809
“…2004a,b; Vik et al., 2004; Chia et al., 2006; Kruk and Schwalbe, 2006), followed by HIV (8 reviews) (Fogarty et al., 2002; Mills et al., 2006; Malta et al., 2008; Vreeman et al., 2008; Lovejoy and Suhr, 2009; Parienti et al., 2009; Ramos, 2009; Reisner et al., 2009), and psychiatric…”
BackgroundRosenfield, S., & Mouzon, D. (2013) · Handbooks of Sociology and Social Research · doi:10.1007/978-94-007-4276-5_14 · Cited by 494
Degenhardt, L., Mathers, B., Vickerman, P., Rhodes, T., Latkin, C., & Hickman, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60742-8 · Cited by 423
Wolfe, D., Carrieri, M. P., & Shepard, D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60832-x · Cited by 418
MacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., Degenhardt, L., & Hickman, M. (2012) · BMJ · doi:10.1136/bmj.e5945 · Cited by 410
Metadata
- Authors
- Malta, M., Strathdee, S. A., Magnanini, M. M. F., & Bastos, F. I.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2008-07-15
- Volume
- 103
- Issue
- 8
- Pages
- 1242-1257
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2111041960
- Cited by
- 283
- References
- 58
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.